Repotrectinib/TPX-0005
ISO
1802220-02-5
Pharmaceutical Grade
99%
qingdao
Million
1kg/bag
2024-01-25
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Repotrectinib
Other Name:Repotrectinib;TPX-0005;1802220-02-5;08O3FQ4UNP;TPX0005;UNII-08O3FQ4UNP;TRX-0005;Repotrectinib (USAN);Repotrectinib [USAN];(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one
CAS No.:1802220-02-5
Molecular Formula:C18H18FN5O2
InChIKeys:FIKPXCOQUIZNHB-WDEREUQCSA-N
Molecular Weight:355.4
Exact Mass:355.14445300
UNII:08O3FQ4UNP
NCI Thesaurus Code:C133821
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Location:
Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China
-
Payment Terms:
L/C,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2012
-
Certifications:
business license
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product

